We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£495.00
The 2023-2028 Outlook for Peptides and Heparin for Diabetes in Japan
Price data last checked 133 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£495 today · cheaper than every other day in the last 16 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 337 days • 337 data points (No recent data available)
Price Distribution
Price distribution over 337 days • 1 price levels
Price Analysis
Most common price: £495 (337 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 337 days
Product Specifications
- Format
- paperback
- ASIN
- B0BP9Z9V9L
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 28 November 2022
- Listed Since
- 08 December 2022
Similar Products You Might Like
The 2023-2028 Outlook for Peptides and Heparin for Diabetes in India
The 2023-2028 Outlook for Peptides and Heparin for Diabetes in the United States
The 2025-2030 World Outlook for Peptides and Heparin for Diabetes
The 2023-2028 Outlook for Peptides and Heparin for Diabetes for US Zip Codes
The 2019-2024 Outlook for Diabetes Drugs in the United States
The 2023-2028 Outlook for GLP-1 Agonists for Type 2 Diabetes in China
The 2023-2028 Outlook for Diabetes Treatments in Japan
The 2023-2028 Outlook for Diabetes Care Products in Japan
The 2016-2021 Outlook for Insulins and Anti-Diabetic Hormones and Synthetic Substitute Pharmaceuticals in Japan
The 2023-2028 Outlook for Diabetes Treatment Devices in Japan
The 2016-2021 Outlook for Insulins and Anti-Diabetic Hormones and Synthetic Substitute Pharmaceuticals in the United States
The 2016-2021 Outlook for Insulins and Anti-Diabetic Hormones and Synthetic Substitute Pharmaceuticals in India
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Japan
The 2023-2028 Outlook for Diabetes Treatments in China
The 2023-2028 Outlook for Diabetes Care Products in China
The 2023-2028 Outlook for Diabetes Care Products in the United States
The 2023-2028 Outlook for Diabetes Treatment Devices in China
The 2023-2028 World Outlook for Injectable Diabetes Drugs
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in the United States
The 2023-2028 Outlook for Diabetes Treatments in India
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in India
The 2023-2028 Outlook for Diabetes Care Products in India
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Europe
